Convergence of decreasing male and increasing female incidence rates in major tobacco-related cancers in Europe in 1988–2010
Open accessAbstract
Introduction Smoking prevalence has been declining in men all over Europe, while the trend varies in European regions among women. To study the impact of past smoking prevalence, we present a comprehensive overview of the most recent trends in incidence, during 1988-2010, in 26 countries, of four of the major cancers in the respiratory and upper gastro-intestinal tract associated with tobacco smoking. Methods Data from 47 population-based cancer registries for lung, laryngeal, oral cavity and pharyngeal, and oesophageal cancer cases were obtained from the newly developed data repository within the European Cancer Observatory (http://eco.iarc.fr/). Truncated age-standardised incidence rates (35-74 years) by calendar year, average annual percentage change in incidence over 1998-2007 were calculated. Smoking prevalence in selected countries was extracted from the Organisation for Economic Co-operation and Development and the World Health Organization databases. Results There remained great but changing variation in the incidence rates of tobacco-related cancers by European region. Generally, the high rates among men have been declining, while the lower rates among women are increasing, resulting in convergence of the rates. Female lung cancer rates were above male rates in Denmark, Iceland and Sweden (35-64 years). In lung and laryngeal cancers, where smoking is the main risk factor, rates were highest in central and eastern Europe, southern Europe and the Baltic countries. Despite a lowering of female smoking prevalence, female incidence rates of lung, laryngeal and oral cavity cancers increased in most parts of Europe, but were stable in the Baltic countries. Mixed trends emerged in oesophageal cancer, probably explained by differing risk factors for the two main histological subtypes. Conclusions This data repository offers the opportunity to show the variety of incidence trends by sex among European countries. The diverse patterns of trends reflect varied exposure to risk factors. Given the heavy cancer burden attributed to tobacco and the fact that tobacco use is entirely preventable, tobacco control remains a top priority in Europe. Prevention efforts should be intensified in central and eastern Europe, southern Europe and the Baltic countries.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In most transitioned countries, lung cancer rates in women are still rising, with only a few countries (e.g., the United States) showing signs of stabilization or decline.
“In most transitioned countries, lung cancer rates in women are still rising, 18 with only a few countries (e.g., in the United States) showing signs of a stabilization or decline in rates.18,19”
From Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. (2024) · cites this paper as [18]
Section 3.1 (page unavailable) reports that female lung cancer incidence generally increased in the European countries studied. It also identifies early signs of stabilization after 2005 across several European regions, Switzerland and Malta. The paper does not establish the claim for most transitioned countries worldwide or document a US stabilization or decline. (LLM, conf=0.86)
Experimental — accuracy not yet measuredIncidence rates in women are approaching or surpassing those in men in several countries at younger or middle ages and in recent generations in Europe and Northern America.
“The net result is that incidence rates in women are approaching or surpassing those in men in several countries at younger or middle ages and in recent generations in Europe and Northern America, 18,20,21 forewarning of a relatively higher overall lung cancer burden among women in future decades.”
From Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. (2024) · cites this paper as [18]
Sections 3.1 and 4.1 (pages unavailable) report that male and female lung cancer incidence rates are converging in Europe, with rates among women aged 35–64 exceeding those among men in Denmark, Iceland and Sweden in 2006–2008. The paper does not establish the claim for Northern America or for recent birth generations. (LLM, conf=0.88)
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
The citation lists haven’t been fetched yet
References 44 · Cited by 186
Research works printed but not linked: 1
- Cancer Registry (Dr. Gozdz); Slovakia -Slovakia Na- tional Cancer Registry (Dr. Safaei Diba, Dr. Kaiser- ova); Slovenia -Cancer Registry of Republic of Slovenia (Prof Primic Z ˇakelj); Spain -Granada Cancer Registry (Dr. Sanchez-Perez), Murcia Cancer Registry (Dr. Navarro Sa ´nchez), Navarra Cancer Registry (Dr. Ardanaz Aicua), Tarragona Cancer Registry (Prof Peris-Bonet, Dr. Galceran); Sweden -Swedish Cancer Registry (Ms Klint, Dr. Heyman); Switzerland -Geneva Cancer Registry (Prof Bouchardy), St. Gallen-Appenzell Cancer Registry (Prof Kuehni, Dr. Ess), The Nether- lands -The Netherlands Cancer Registry, Comprehen- sive Cancer Centre South (Dr. De Ridder-Sluiker); United Kingdom -Eastern England, Northern and Yorkshire Cancer Registry, North West Cancer Intelli- gence Service, Oxford Cancer Intelligence Unit, South West Cancer Registry (Mr David Meecham, Dr. Gill Lawrence, Dr. Stiller); Russian Federation -Russian Centre for technologic information and epidemiological studies in the field of oncology. References
- Authors
- Lortet-Tieulent, J., Renteria, E., Sharp, L., Weiderpass, E., Comber, H., Baas, P., Bray, F., Coebergh, J. W., & Soerjomataram, I.
- Affiliations
- Karolinska Institutet (SE)
- The Netherlands Cancer Institute (NL)
- Centre international de recherche sur le cancer (FR)
- Erasmus MC (NL)
- Corresponding author
- Soerjomataram, Isabelle
- ORCID
- Venue
- European Journal of Cancer
- Publisher
- Elsevier BV
- Published
- 2015-06
- Volume
- 51
- Issue
- 9
- Pages
- 1144-1163
- ISSN
- 0959-8049 (ISSN-L)
- OpenAlex
- W2037450389
- Cited by
- 186
- References
- 44
- Citations by year
- 2026: 7 · 2025: 17 · 2024: 14 · 2023: 10 · 2022: 17 · 2021: 30 · 2020: 20 · 2019: 11 · 2018: 15 · 2017: 10 · 2016: 8 · 2015: 18 · 2014: 8 · 2013: 1
- FWCI
- 6.25
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- European Journal of Cancer (publishedVersion)
- PubMed (publishedVersion)
- EUR Research Repository (Erasmus University Rotterdam) (publishedVersion, other-oa)
- EUR Research Repository (Erasmus University Rotterdam) (submittedVersion, other-oa)
- RePub (Erasmus University Rotterdam) (submittedVersion, other-oa)
- Topics
- Health Sciences › Medicine › Oncology › Global Cancer Incidence and Screening
- Health Sciences › Medicine › Physiology › Smoking Behavior and Cessation
- Health Sciences › Medicine › Otorhinolaryngology › Head and Neck Cancer Studies
- Keywords
- tobacco-related cancer, cancer incidence trends, sex differences in cancer incidence, lung cancer, laryngeal cancer, oral cancer, pharyngeal cancer, esophageal cancer, smoking prevalence, tobacco control, age-standardized incidence rate
- MeSH terms
- Adult, Age Factors, Aged, Europe, Female, Humans, Lung Neoplasms, Male, Middle Aged, Neoplasms, Registries, Sex Factors, Smoking, Tobacco Products, Nicotiana, Incidence
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review